compounded tirzepatide urbana led and built for women Compounded & Pre Mixed Tirzepatide

Ozempic has been shown to: Reduce HbA1c (a measure of long-term blood glucose control) by 11.5% on average, with variations depending on baseline levels and dose Improve insulin sensitivity, primarily as a consequence of weight reduction Reduce visceral adiposity (fat around internal organs) as part of overall weight loss, which is particularly beneficial for cardiovascular health Lower blood pressure modestly in many patients Improve lipid profiles, including reductions in triglycerides It is important to note that weight loss is not universalsome patients experience minimal weight change whilst still achieving improved glycaemic control

Glucagon Receptor Limb GCGR agonism is the mechanistic element unique to triple agonists and the most physiologically complex

How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context about your individual peptide pathway predispositions relevant to GLP-1 effectiveness

One acts narrowly at MC1R, the other broadly across the melanocortin receptor family

In parallel, we also released a companion report looking at GLP-1 prescription data to establish a current view of utilization trends